This $400 Million Pot Stock Can Go to $2 Billion

Molson Coors Canada Inc. (TSX:TPX.B)(NYSE:TAP) is one of the most popular brands in Canada. Its market cap exceeds $10 billion, giving it plenty of liquidity to pursue long-term growth opportunities. If you look closely, it’s clear that Molson is about to send shares of one pot stock soaring. It’s important to note that Molson hasn’t entered the marijuana industry directly.…

Read More

Should You Buy Canopy Growth (TSX:WEED) or Aurora Cannabis (TSX:ACB) Stock?

Everyone knows that diversification is key to investing, as it protects investors from too much exposure into one specific sector. Having cannabis stocks in your portfolio may be a great idea if you are looking for a well-rounded portfolio. In Canada, marijuana has been legalized for medical use since 2001 and recreational use since 2018. This has allowed the industry…

Read More

Buy Alert: This Pot Stock Is Exploding Higher

Pot stocks had a tough 2019. The start of 2020 was no easier. Since their all-time highs, many marijuana companies have seen their shares reduced by 70% or more. Recent weeks have been a different story. One producer in particular has seen its stock move from $0.60 to $1.50 in just 20 days. There’s reason to believe this momentum will…

Read More

Turn $1,000 Into $4,000 With This Pot Stock

Everyone wants to find a multi-bagger stock. That’s an investment that could double, triple, or even quadruple in value. These opportunities aren’t easy to find, but one pot stock looks the part. Before we jump into the stock pick, it’s critical to understand the recent history of marijuana. A volatile beginning In 2018, Canada passed the Cannabis Act, which paved…

Read More

The #1 Pot Stock to Buy During the Market Rally

The market rally picked up steam in recent weeks, yet many pot stocks remain depressed — and for good reason. If you want to go bargain shopping for marijuana stocks, you need to be careful. Today, some pot stocks are priced at ridiculous valuations. Fortunes are ready to be made. Other pot stocks, however, face a difficult future — one…

Read More

Will Cronos (TSX:CRON) Stock Fall Below $5?

Cronos Group (TSX:CRON)(NASDAQ:CRON) was once the hottest pot company in the world. From late 2014 to early 2019, Cronos stock rose in value by nearly 4,000%. The marijuana bear market of 2019 changed everything. Last year, virtually every pot stock lost more than 50% of its value. Cronos went from a $12 billion company to a valuation of less than…

Read More

Canopy Growth Stock Lagged the TSX by 5.7% in March

Canopy Growth (TSX:WEED)(NYSE:CGC) stock price was already in the throes of despair before the coronavirus crisis. The stock had already fallen dramatically from late 2018/early 2019 highs as the cannabis bubble burst. In March, Canopy Growth stock price continued to underperform the TSX, lagging it by 5.7%. During the month of March, all eyes were on developments related to the…

Read More

3 Top Marijuana Stocks to Watch in April

Investors in top Canadian marijuana stocks have much to look forward to during April. Some top cannabis producers are scheduled to report this month, and one industry is rushing against time to avoid defaulting on updated loan covenants. Let’s have a quick look at which top marijuana stocks to closely watch this month. A well-placed Aphria Top marijuana firm Aphria…

Read More

Forget Aurora Cannabis (TSX:ACB) and Invest in This Marijuana Stock Instead!

Equity markets are making a comeback this week after several governments announced a slew of economic measures to fight COVID-19. In the last three days, the iShares S&P/TSX 60 Index has gained close to 20%. This recovery has driven stocks of a number of companies higher. Several marijuana stocks are roaring back to life as well after a disappointing 2019.…

Read More

We’re Months Away From Bankruptcies in the Cannabis Sector

In early 2019, if someone were to suggest that by the end of 2020, we’d start seeing bankruptcies in Canada’s cannabis sector, you would most certainly have concluded they were smoking something. Here we are a year later, and these concerns don’t seem so far-fetched. Cannabis companies have exhibited a general lack of fiscal prudence over the past year. Examples…

Read More